Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk

Abstract

IntroductionDeficient 25-hydroxyvitamin D (25(OH)D) levels have been associated with dyslipidemia and cardiovascular diseases, though the underlying mechanism of these associations is uncertain. We analyzed associations between vitamin D and other non-lipid biomarkers of cardiovascular risk to better elucidate possible relationships between deficient 25(OH)D and cardiovascular disease.Material and methodsWe performed a cross-sectional analysis of 4,591 adults included in a clinical laboratory database from 2009 to 2011 with available measurements for 25(OH)D and the following biomarkers: homocysteine (Hcy), high-sensitivity C-reactive protein (hs-CRP), cystatin-C, creatinine, γ-glutamyltransferase (GGT), uric acid, and hemoglobin A1c (HbA1c). We calculated odds ratios (OR) of having high levels of each biomarker associated with 25(OH)D deficiency (< 20 ng/ml) compared to optimal levels (≥ 30 ng/ml) using logistic regression adjusted for age, sex, and lipids.ResultsThe mean ± SD age was 60 ±14 years and 46% of patients were women. In multivariable-adjusted models, adults with deficient 25(OH)D compared to those with optimal levels had increased odds of elevated biomarkers as follows: Hcy (OR = 2.53, 95% CI: 1.92–3.34), hs-CRP (1.62, 1.36–1.93), cystatin-C (2.02, 1.52–2.68), creatinine (2.06, 1.35–3.14), GGT (1.39, 1.07–1.80), uric acid (1.60, 1.31–1.95), and HbA1c (2.47, 1.95–3.13). In analyses evaluating women and men separately, 25(OH)D deficient women but not men had increased odds of elevated levels of all biomarkers studied. There were significant interactions based on sex between 25(OH)D and Hcy (p = 0.003), creatinine (p = 0.004), uric acid (p = 0.040), and HbA1c (p = 0.037).ConclusionsDeficient 25(OH)D is associated with elevated levels of many biomarkers of cardiovascular risk, particularly among women, in a United States population.

Klotho and vitamin D in multiple sclerosis: an Italian study

“…In the last decades, a role of hypovitaminosis D has emerged [3]. Since the discovery of vitamin D immunomodulatory function, vitamin D has been proposed as a serum biomarker in several clinical conditions, including neurodegenerative disorders, along with inflammatory and cardiovascular markers [4][5][6][7][8][9][10][11][12][13][14][15][16].…”

The role of vitamin D in perinatology. An up-to-date review

“…Vitamin D is an important link in inflammatory pathways [31]. It regulates immunological, circulatory and neurological processes [3,[32][33][34][35][36]. In adults (but also in the perinatal period) vitamin D regulates the immune system and is an anti-inflammatory agent that slows down the expression of pro-inflammatory cytokines and chemokines such as tumor necrosis factor α (TNF-α), interferon γ (INF-γ), and interleukin 6 (IL-6) [31,34,[37][38][39].…”

Ankyrins in human health and disease – an update of recent experimental findings

“…Ankyrins, especially ANK B and spectrins, are related to electrical and structural forms of heart diseases [18]. Recently ANK as well as cardiolipin-1, adipokines, galectin-3 and vitamin deficiency have been considered potential biomarkers of cardiovascular diseases [31][32][33], in addition to standard risk factors such as hypercholesterolaemia [34]. These biomarkers are supposed to be crucial to apply the best therapy in heart failure and predicting the risk of cardiovascular development [35].…”